Novo has backed automated molecule and material discovery business Kebotix, co-founded by former Harvard University professor Alán Aspuru-Guzik.

The flash storage system provider secured series C funding from investors including Siemens, Dell and Mellanox, valuing it at $1.2bn.

The E-Town Biomedical Park-backed biopharmaceutical company, which has some 15 assets in clinical trials, has completed a two-tranche series C round.

Long-term investors Johnson & Johnson Innovation, JJDC and Pfizer Ventures took part in a round that boosted the radiotherapy developer's overall funding to $264m.

The radiotherapy developer, which is exploiting UChicago research, has now raised $264m in funding overall.

Family office Perwyn led a round that will help Unilever-backed Gousto deal with increased demand for its meal kit delivery service.

The Baidu-backed advanced chemicals developer secured $11.4m in a series A round featuring Novo with a targeted close of $15m.

The traffic analysis-based cybersecurity software developer took its total funding to near $80m in a Liberty Global-backed series C round.

GV has contributed to the $30m in funding revealed by on-demand cloud network service Alkira when it emerged from stealth this week.

Emergent BioSolutions-backed Avectas has added $20m to its coffers to help drug developers create cancer treatments.